MEDIFAST Net Income From Continuing Ops from 2010 to 2026
| MED Stock | USD 11.19 0.27 2.36% |
Net Income From Continuing Ops | First Reported 2000-03-31 | Previous Quarter 2.5 M | Current Value -2.3 M | Quarterly Volatility 12.3 M |
Check MEDIFAST INC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MEDIFAST INC's main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.3 M, Interest Expense of 5.8 M or Selling General Administrative of 495.7 M, as well as many indicators such as Price To Sales Ratio of 0.27, Dividend Yield of 0.0032 or PTB Ratio of 0.78. MEDIFAST financial statements analysis is a perfect complement when working with MEDIFAST INC Valuation or Volatility modules.
MEDIFAST | Net Income From Continuing Ops | Build AI portfolio with MEDIFAST Stock |
Latest MEDIFAST INC's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of MEDIFAST INC over the last few years. It is MEDIFAST INC's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MEDIFAST INC's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
MEDIFAST Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | 52,590,004 | |
| Geometric Mean | 27,649,204 | |
| Coefficient Of Variation | 97.00 | |
| Mean Deviation | 41,002,468 | |
| Median | 36,409,000 | |
| Standard Deviation | 51,014,349 | |
| Sample Variance | 2602.5T | |
| Range | 161.9M | |
| R-Value | 0.27 | |
| Mean Square Error | 2573T | |
| R-Squared | 0.07 | |
| Significance | 0.29 | |
| Slope | 2,731,948 | |
| Total Sum of Squares | 41639.4T |
MEDIFAST Net Income From Continuing Ops History
About MEDIFAST INC Financial Statements
MEDIFAST INC stakeholders use historical fundamental indicators, such as MEDIFAST INC's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although MEDIFAST INC investors may analyze each financial statement separately, they are all interrelated. For example, changes in MEDIFAST INC's assets and liabilities are reflected in the revenues and expenses on MEDIFAST INC's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in MEDIFAST INC. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 2.4 M | 2.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:Check out the analysis of MEDIFAST INC Correlation against competitors. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Will Personal Care Products sector continue expanding? Could MEDIFAST diversify its offerings? Factors like these will boost the valuation of MEDIFAST INC. Expected growth trajectory for MEDIFAST significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every MEDIFAST INC data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.87) | Earnings Share 0.02 | Revenue Per Share | Quarterly Revenue Growth (0.36) | Return On Assets |
Investors evaluate MEDIFAST INC using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating MEDIFAST INC's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause MEDIFAST INC's market price to deviate significantly from intrinsic value.
Understanding that MEDIFAST INC's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MEDIFAST INC represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, MEDIFAST INC's market price signifies the transaction level at which participants voluntarily complete trades.